Australia - English - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - borago officinalis,d-alpha-tocopherol,fish oil - natural,rosemary oil -

Australia - English - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - d-alpha-tocopherol,fish oil - natural,rosemary oil -

Canada - English - Health Canada

bavarian nordic as - modified vaccinia virus (ankara-bavarian nordic) - suspension - 50000000ccid50 - modified vaccinia virus (ankara-bavarian nordic) 50000000ccid50 - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

hydrosilex australia pty ltd - 9951 - disinfectant, household/commercial grade - other therapeutic

United States - English - NLM (National Library of Medicine)

bavarian nordic a/s - vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen (unii: tu8j357395) (vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen - unii:tu8j357395) - jynneos is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. available human data on jynneos administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. the effect of jynneos on embryo-fetal and post-natal development was evaluated in four developmental toxicity studies conducted in female rats and rabbits. in two studies, rats were administered a single human dose of jynneos (0.5 ml) once prior to mating and on one or two occasions during gestation. in the third study, rats were administered a single human dose of jynneos (0.5 ml) on two occasions during gestation. in the fourth study, rabbits were ad

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - misoprostol - oral tablet - 400microgram

European Union - English - EMA (European Medicines Agency)

bavarian nordic a/s - modified vaccinia ankara - bavarian nordic (mva-bn) virus - smallpox vaccine; monkeypox virus - other viral vaccines, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4.4 and 5.1).the use of this vaccine should be in accordance with official recommendations.

United States - English - NLM (National Library of Medicine)

the nordic shield aps - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

Australia - English - Department of Health (Therapeutic Goods Administration)

new nordic pty ltd - melissa officinalis, quantity: 300 mg (equivalent: melissa officinalis, qty 3 g); camellia sinensis, quantity: 150 mg (equivalent: camellia sinensis, qty 4.5 g; equivalent: caffeine, qty 3 mg); matricaria chamomilla, quantity: 100 mg (equivalent: matricaria chamomilla, qty 500 mg); magnesium oxide, quantity: 103.45 mg (equivalent: magnesium, qty 60 mg); nicotinamide, quantity: 6 mg; pyridoxine hydrochloride, quantity: 0.99 mg (equivalent: pyridoxine, qty 0.666 mg); cyanocobalamin, quantity: 0.5 microgram; riboflavine, quantity: 0.539 mg; thiamine nitrate, quantity: 0.705 mg (equivalent: thiamine, qty 0.47 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; silicon dioxide; carmellose sodium; hypromellose; mannitol - soothe/calm nerves ; maintain/support nervous system function ; enhance/promote/increase refreshing sleep ; maintains/supports refreshing sleep ; decrease/reduce time to fall asleep

Australia - English - Department of Health (Therapeutic Goods Administration)

new nordic pty ltd - punica granatum, quantity: 75 mg (equivalent: punica granatum, qty 1.125 g); camellia sinensis, quantity: 75 mg (equivalent: camellia sinensis, qty 1.875 g; equivalent: caffeine, qty 7.5 mg); pinus pinaster, quantity: 40 mg (equivalent: pinus pinaster, qty 320 mg); juglans regia, quantity: 25 mg (equivalent: juglans regia, qty 125 mg); ginkgo biloba, quantity: 60 mg (equivalent: ginkgo biloba, qty 3 g); piper nigrum, quantity: 3 mg (equivalent: piper nigrum, qty 105 mg); riboflavine, quantity: 0.85 mg; nicotinamide, quantity: 4.5 mg; folic acid, quantity: 0.1 mg; cyanocobalamin, quantity: 1.35 microgram; calcium pantothenate, quantity: 3.81 mg (equivalent: pantothenic acid, qty 3.505 mg); pyridoxine hydrochloride, quantity: 1.586 mg (equivalent: pyridoxine, qty 1.06 mg); thiamine nitrate, quantity: 0.987 mg (equivalent: thiamine, qty 0.66 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; silicon dioxide; glycerol; hypromellose; carmellose sodium; soluble potato starch; mannitol - relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; enhance/improve/promote/increase cognitive performance ; enhance/improve/promote/increase memory/recall ; maintain/support nervous system function